GABAPENTIN
- Product NDC
- 62207-922
- 11-digit product format
- 622070922
- Labeler code
- 62207
- Product ID
- 62207-922_b820e737-da30-5009-e053-2a95a90aab2d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Granules India Limited
- Application
- ANDA075360
- Marketing category
- ANDA
- Marketing start
- 2020-09-15
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62207-922 | GABAPENTIN CAPSULE [GRANULES INDIA LIMITED] | 3 | Legacy NDC | 20230217_2caac299-574d-4921-a5b8-dc9287426f11.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62207-922-43 | 62207092243 | 100 CAPSULE in 1 BOTTLE (62207-922-43) | 100 capsule | 2020-09-15 | 0000-00-00 | No | No | Current |
| 62207-922-47 | 62207092247 | 500 CAPSULE in 1 BOTTLE (62207-922-47) | 500 capsule | 2020-09-15 | 0000-00-00 | No | No | Current |
| 62207-922-49 | 62207092249 | 1000 CAPSULE in 1 BOTTLE (62207-922-49) | 1000 capsule | 2020-09-15 | 0000-00-00 | No | No | Current |